144 related articles for article (PubMed ID: 15921208)
1. New immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polyposis.
Gosepath J; Brieger J; Mann WJ
Am J Rhinol; 2005; 19(2):111-6. PubMed ID: 15921208
[TBL] [Abstract][Full Text] [Related]
2. Expression and localization of cyclooxigenases (Cox-1 and Cox-2) in nasal respiratory mucosa. Does Cox-2 play a key role in the immunology of nasal polyps?
Gosepath J; Brieger J; Gletsou E; Mann WJ
J Investig Allergol Clin Immunol; 2004; 14(2):114-8. PubMed ID: 15301300
[TBL] [Abstract][Full Text] [Related]
3. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps.
Gosepath J; Brieger J; Lehr HA; Mann WJ
Am J Rhinol; 2005; 19(1):7-13. PubMed ID: 15794068
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma.
Pujols L; Mullol J; Alobid I; Roca-Ferrer J; Xaubet A; Picado C
J Allergy Clin Immunol; 2004 Oct; 114(4):814-9. PubMed ID: 15480320
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin-sensitive and aspirin-tolerant patients.
Owens JM; Shroyer KR; Kingdom TT
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):579-87. PubMed ID: 16785401
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis.
Pérez-Novo CA; Watelet JB; Claeys C; Van Cauwenberge P; Bachert C
J Allergy Clin Immunol; 2005 Jun; 115(6):1189-96. PubMed ID: 15940133
[TBL] [Abstract][Full Text] [Related]
7. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma.
Adamjee J; Suh YJ; Park HS; Choi JH; Penrose JF; Lam BK; Austen KF; Cazaly AM; Wilson SJ; Sampson AP
J Pathol; 2006 Jul; 209(3):392-9. PubMed ID: 16583357
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide induction of cyclooxygenase-2 in long-term nasal epithelial cultures in cystic fibrosis.
Rozsasi A; Keck T
Arch Otolaryngol Head Neck Surg; 2010 Apr; 136(4):335-9. PubMed ID: 20403848
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis.
Rozsasi A; Heinemann A; Keck T
Am J Rhinol Allergy; 2011; 25(6):e251-4. PubMed ID: 22185734
[TBL] [Abstract][Full Text] [Related]
10. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase and lipoxygenase enzymes in sinonasal mucosa of patients with cystic fibrosis.
Owens JM; Shroyer KR; Kingdom TT
Arch Otolaryngol Head Neck Surg; 2008 Aug; 134(8):825-31. PubMed ID: 18711055
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase-2 in human hyperplastic gastric polyps.
Bamba H; Ota S; Arai S; Ban S; Shimizu M; Imai Y; Kawamoto C; Yoshida Y; Fujiwara K
J Exp Clin Cancer Res; 2003 Sep; 22(3):425-30. PubMed ID: 14582702
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics.
Picado C; Fernandez-Morata JC; Juan M; Roca-Ferrer J; Fuentes M; Xaubet A; Mullol J
Am J Respir Crit Care Med; 1999 Jul; 160(1):291-6. PubMed ID: 10390414
[TBL] [Abstract][Full Text] [Related]
14. Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics.
Adamusiak AM; Stasikowska-Kanicka O; Lewandowska-Polak A; Danilewicz M; Wagrowska-Danilewicz M; Jankowski A; Kowalski ML; Pawliczak R
Int Arch Allergy Immunol; 2012; 157(4):354-62. PubMed ID: 22123288
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase in nasal polyps from atopic and nonatopic subjects.
Grzegorczyk J; Kowalski ML; Kornatowski T; Pawliczak R
J Investig Allergol Clin Immunol; 1999; 9(6):380-5. PubMed ID: 10664933
[TBL] [Abstract][Full Text] [Related]
16. Topical glucocorticoids downregulate COX-1 positive cells in nasal polyps.
Ebbens FA; Maldonado M; de Groot EJ; Alobid I; van Drunen CM; Picado C; Fokkens WJ; Mullol J
Allergy; 2009 Jan; 64(1):96-103. PubMed ID: 19132974
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and children featuring nasal polyps.
Hu KH; Lee FP; Cheng YJ; Huang HM
Int J Pediatr Otorhinolaryngol; 2007 Jan; 71(1):23-8. PubMed ID: 16987554
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas.
Borzacchiello G; Paciello O; Papparella S
J Comp Pathol; 2004 Jul; 131(1):70-6. PubMed ID: 15144801
[TBL] [Abstract][Full Text] [Related]
19. Expression of survivin and enhanced polypogenesis in nasal polyps.
Qiu ZF; Han DM; Zhang L; Zhang W; Fan EZ; Cui SJ; Huang Q; Wang XD
Am J Rhinol; 2008; 22(2):106-10. PubMed ID: 18336724
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps.
Rho HS; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Park MK; Kang SM
Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):985-9. PubMed ID: 16982975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
